TrialBritish journal of haematology2026

Checkpoint inhibitors, obinutuzumab plus PET-adapted ultra-low dose nodal radiotherapy yield high efficacy in treatment-naïve follicular lymphoma: Results from the phase II 'FLUORO' study.

Arina Martynchyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.